Navigation Links


attacks at medicine technology

Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Women's Health Initiative Data

...ll-recognized as a strong predictorof future heart attacks and other coronary events. Using cardiac CTscans, CAC was measured in 1064 WHI women. After adjustment forother coronary risk factors, the risks of having mild-to-moderateCAC were 20 to 30 percent lower and the risks of severe CAC were 40percent lowe...

Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology

...whichis targeted by the Can-Fite's drugs. The drug attacks inflammatorycells and leads to programmed cell death (apoptosis) andsuppression of the inflammatory process. Can-Fite is using humancells to investigate the effects and mechanism of action of CF502.The Company is currently finalizing the development ...

Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma

...ics is working to develop products foracute asthma attacks that lead patients to the emergency room andother urgent care settings. The Company also is developingtherapies directed toward the body's inflammatory response.Critical Therapeutics is located in Lexington, Mass. For moreinformation, please visit ww...

Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks

...ainesymptoms at two and four hours across multiple attacks with justone tablet. The findings will be presente...dache Society. In addition to head pain, migraine attacks often include nausea,vomiting and sensitivity to light or sound, making it difficult forsufferers to...

Merck's Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study

...like a bad headache, migraines are characterizedby attacks of intense, usually one-sided, throbbing head pain thatcan last from four to 72 hours. The pain associated with migraineis frequently accompanied by other associated symptoms, includingnausea, vomiting and increased sensitivity to light and/orsound. ...

Alexza Pharmaceuticals to Present AZ-004 (Staccato Loxapine) Clinical Data at the Annual NCDEU Meeting

...accato alprazolam) for theacute treatment of panic attacks associated with panic disorder,AZ-003 (Staccato fentanyl) for the treatment of patients with acutepain and AZ-007 (Staccato zaleplon) for the treatment of sleepdisorder in patients who have difficulty falling asleep. CONTACT: Thomas B. King, Pesid...

GSK'S Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

...na and cerebrovascularaccidents/transient ischemic attacks have been reported. The mostcommon laboratory abnormality was an elevation in livertransaminase which occurred as an asymptomatic, reversibleevent. About GlaxoSmithKline GlaxoSmithKline -- one of the world's leading research-basedpharmaceutical and...

Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema

...of C1-INHreplacement therapy in treating acute HAE attacks and asprophylactic treatment to prevent HAE attack...g approval of C1-INH for the acutetreatment of HAE attacks based on the results of the first portionof the CHANGE study. The results from the prophylactic port...

Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at the American Headache Society Meeting

...accato alprazolam) for theacute treatment of panic attacks associated with panic disorder,AZ-003 (Staccato fentanyl) for the treatment of patients with acutepain and AZ-007 (Staccato zaleplon) for the treatment of sleepdisorder in patients who have difficulty falling asleep. CONTACT: Thomas B. King, Presi...

Mild Asthma, a Revolutionary Therapy from Italian Research

... thedisease is not correctly managed, symptoms and attacks occur muchmore frequently. Some of the reasons why patients fail to stick totherapy include the complex nature and the frequency of thetreatment, the administration of a number of drugs several times aday, the fear of side effects, even in the long-t...

Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases

...ritis and psoriasis, where aperson's immune system attacks their own body tissues trying toheal and repair them, but ultimately causing inflammation. Chronicinflammatory diseases afflict millions of people worldwide and area physical, social and economic burden to patients and theirfamilies. Despite the burd...

PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week

...severe form ofthis inflammatory bowel disease that attacks the colon. Summary of Results (Abstract T1279) In the study presented by Dr. Sandborn, 138 subjects withIVSR-UC were treated with visilizumab at 5, 7.5, 10, 12.5 or 15mg/kg intravenously on two consecutive days (Days 1 and 2).Eighty-nine (64.5%) of...

FDA Issues Safety Alert on Avandia

...d anew warning about a potential increase in heart attacks andheart-related chest pain in some individuals using Avandia. Thisnew warning was based on the result of a controlled clinical trialin patients with existing congestive heart failure. Recently, the manufacturer of Avandia provided FDA with a pooled...

Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients

... elevated LDL-C levels beginning at birth andheart attacks at an early age. People with the disease haveconsistently high levels of LDL-C, which leads to prematureatherosclerosis of the coronary arteries. Current therapies for FHare inadequate, and the most severely affected patients may needapheresis, an ex...

Data to be presented at AAN Meeting -Study results of drug candidate for MS

...ts in relapsing forms involving acuteself-limiting attacks of neurological dysfunction (or "relapses")followed by complete or partial restoration of functions. Preclinical studies FTY720's previously known activity is based on its ability tobind to the sphingosine 1-phosphate receptor-1 (S1P-R1) oncirculat...

Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting

... central nervous system in which the immune system attacks anddestroys the structure, and therefore degrades the function, ofnerve cells. Approximately 400,000 Americans have MS, and everyweek about 200 people are newly diagnosed. Most are between theages of 20 and 50, and women are affected two to three tim...

Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms

... nausea orsensitivity to light and sound, migraine attacks can also involvesymptoms like neck pain or sinus p... migrainetreatment Trexima early in their migraine attacks were pain free attwo hours and experienced relief from both traditional andnon-traditional symptoms,...

Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks

...oduced consistentpain-free results across multiple attacks in the same patient." Trexima, the proposed bra...s. Most patients(80 percent) treated three of four attacks with Trexima and theremaining attack with placebo; the remaining patients treated allfour attacks wi...

Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria

...protectpatients suffering from recurrent porphyria attacks and/orneuropathy. AMT-020 is comprised of an Aden...isk of primary liver cancer and renal failure. The attacks arenormally triggered when the haem synthesis is induced byinfections, stress, alcohol, hormones, or...

New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting

...the transplanted organ. Thepatient's immune system attacks the heart as if it were a foreignobject until it no longer functions properly. The one-year survivalrate after transplantation is approximately 80 percent; this numberdrops to nearly 50 percent after 10 years. About ISHLT The International Society ...

Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine

...of patients. Anaverage migraine patient suffers 12 attacks a year, with an attackduration of between 4 and 72 hours. The prevalence of migraine isestimated at 12%, affecting approximately 30 million people in theUnited States. The disabling nature of migraine often results in asignificant deterioration in qu...

Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology

...thma and an injectable formulation for acuteasthma attacks that lead patients to the emergency room and otherurgent care settings. The Company also is collaborating withMedImmune, Inc. to design antibody therapies that treat acute andchronic diseases triggered by the inflammatory cytokine HMGB1.Research pipe...

DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3)

... designation in the U.S. for thetreatment of acute attacks of HAE. Additionally, Dyax has successfully completed a Phase 1/2 trialof DX-88 for the prevention of blood loss during on-pump coronaryartery bypass graft (CABG) procedures. Dyax is initiating a Phase 2trial for further development of DX-88 in on-p...

New Cardioprotective Drug Could Provide Boost For Post-Bypass Surgery Heart Health

...nical trails cut the threat ofpost-operative heart attacks in bypass patients nearly in half.Medicure's MC-1 is currently in a late-stage clinical trial and ifsuccessful could lead to its approval for sale in the U.S. "MC-1 has the opportunity to be the first drug available to helpthe hundreds of thousands ...

Presentations at American College of Cardiology Meeting Highlight New Opportunities for HDL Therapy

...gs have aproven clinical benefit in reducing heart attacks and stroke;however, the reduction in these clinical events is, at best, onlyapproximately one third. A significant number of patients takingstatins continue to have clinical events, and increasing HDL hasbeen widely accepted as a potential major new ...

Increasing Proportion of Cardiovascular Disease Due to Diabetes Over the Last 50 Years

... cardiovascular “events” such as heart attacks inFramingham study participants from two different time periods. Thefirst group was examined between 1952 and 1974 and the more recentgroup was examined between 1975 and 1998. A total of 9,540individuals age 45 to 64 were evaluated. The risk attribut...

Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show

...wering (IDEAL) trial. "The economicimpact of heart attacks and strokes in the U.S. alone totals morethan $400... the study, Lipitor 80 mgreduced the risk of heart attacks by 46 percent, major coronaryevents by 34 percent, and any cardiovascular event by 21 percentcompare...

Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients

...orLipitor that includes proven reductions in heart attacks andstrokes, impressive average LDL lowering of 39 percent to 60percent, and an established safety profile across a broad range ofpatients," said Dr. Michael Berelowitz, senior vice president ofPfizer's global medical division. New Analysis of the Co...

Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stent's Positive Clinical Profile

... = 0.14). However, fewer patients experiencedheart attacks (MI) when treated with the Endeavor stent (0.6% vs.3.6% for Cypher, p = 0.04) and the combined rate of heart attackand death also was statistically significantly lower among patientsrandomized to the Endeavor stent (2.2% vs. 7.1% for Cypher, p =0.013...

Calcium Plaque Build-up in the Arteries Leads to Coronary Heart Disease in Multi-Ethnic Groups

...aque in the arteries means increased risk of heart attacks anddeath from heart disease in multiple ethnic groups, according tonew findings from the Multi-Ethnic Study of Atherosclerosis (MESA)funded by the National Heart, Lung, and Blood Institute of theNational Institutes of Health. Previous studies have sh...

Acuity One-Year Findings Meet All Primary Endpoints in Favor of Angiomax (Bivalirudin) Alone Treatment Group

...p < 0.0001 forboth comparisons). "While heart attacks tend to happen in the hospital, we foundthe risk of death associated with major bleeding continueslong-term," said Dr. Stone. "This makes major bleeding an even morepowerful predictor of death than having a heart attack." About ACUITY Enrolling 13,...

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC

... elevated LDL-C levels beginningat birth and heart attacks at an early age. Affected people haveconsistently high levels of LDL-C, which leads to prematureatherosclerosis of the coronary arteries. Treatment for FH isinadequate, and the most severely affected patient may undergo anexpensive and time-consuming...

Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis

...f evidence that includes proven reductions inheart attacks and stroke, impressive average LDL lowering of 39 to60 percent, and an established safety profile across a broad rangeof patients," said Dr Berelowitz. Summary of Imaging Trials Results for the Lipitor Arm The three, two-year clinical trials, invol...

Hospitalization Rates for Coronary Artery Disease Decline in the U.S.

... Cardiology. U.S. hospitalization rates for heart attacks (acute myocardialinfarctions) declined 10.6 percent from 2002 to 2005, possibly dueto broader use of preventive treatments such as statin drugs andaspirin, as well as declines in risk factors like smoking. The study is a collaboration between resear...

Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema

...tients suffering from moderate to severe acute HAE attacks inthe face, abdomen or genitals. Laryngeal attacks... attack sites. Additionally, 21 out of 21laryngeal attacks were successfully treated with open-label C1-INH.To date, more than 400 acute treatments of C1-INH h...

JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program

... and marked byrepeated and sometimes unpredictable attacks of chest pain.Approximately 8.9 million people in the United States have chronicangina, and 400,000 new cases are diagnosed annually, according tothe American Heart Association. Ranexa has anti- ischemic effectswhich do not depend on changes in heart...

CV Therapeutics Announces Topline MERLIN TIMI-36 Results

... and marked byrepeated and sometimes unpredictable attacks of chest pain.Approximately 8.9 million people in the United States have chronicangina, and 400,000 new cases are diagnosed annually, according tothe American Heart Association. Ranexa has anti-ischemic effectswhich do not depend on changes in heart ...
Other Contentsmitochondriamitochondriamitochondriamitochondriamitochondriamitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmodificationmodificationmodificationmodificationmodificationmodificationmodificationteethteethteethteethteethteethteethmolarmolarmolarmolarmolar
(Date:5/15/2008)...uantity of nitrogen compounds emitted into the atm...els and the use of nitrogen fertilizers enters the... dioxide from the atmosphere, concluded a team of ...ty Distinguished Professor of Oceanography and Atm...experts from institutions around the world present...
(Date:5/15/2008)...ers Karen Staehling-Hampton, Ph.D., Managing Direc...D., Investigator, collaborated with colleagues fro...se spinal mutations in chick and mouse model syste...ith congenital vertebral abnormalities. , The d...e American Journal of Human Genetics. , Working...
(Date:5/15/2008)...ea may be able to stave off the cognitive deficits...cording to a new study published in the second iss...can Journal of Respiratory and Critical Care Medic...a polyphenols (GTP), administered through drinking...f oxygen during 12-hour night cycles, mimicking th...
(Date:5/14/2008)...hers have developed what they believe is the first... common target used to treat all HIV patients, whi...ugs. , Researchers at the University of Michigan...mpound, and then confirmed in the lab that the com...n established target for AIDS treatment. The prote...
Breaking Biology News(10 mins):Atmosphere threatened by pollutants entering ocean, prof says 2Atmosphere threatened by pollutants entering ocean, prof says 3Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Green tea compounds beat OSA-related brain deficits 2Compound has potential for new class of AIDS drugs 2Regado Biosciences to Present at 19th Annual Piper Jaffray Health Care Conference 6656 1IRIDEX Reports Third Quarter Financial Results 6652 1IRIDEX Reports Third Quarter Financial Results 6652 2IRIDEX Reports Third Quarter Financial Results 6652 3IRIDEX Reports Third Quarter Financial Results 6652 4IRIDEX Reports Third Quarter Financial Results 6652 5IRIDEX Reports Third Quarter Financial Results 6652 6Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U S 1853 1Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U S 1853 2Women arent men 6649 1Women arent men 6649 2Women arent men 6649 3
(Date:5/16/2008)...Newswire/ -- Less than a week after,committing med...stated by,Cyclone Nargis, Project HOPE, an interna...e organization, is again mobilizing its full,resou...or the people of,central China devastated by the m...ives., "I am saddened by the vast loss of life an...
(Date:5/16/2008)...people who didn,t have cancer as children, study f... -- Adults who had cancer as children or teens are... a new study found. , And the heart problems s...d not suffer cancer as children. , Childhood ca...mes increased risk of having heart disease compare...
(Date:5/16/2008)...t The University of Texas M. D. Anderson Cancer Ce... leukemia cells by shutting down their energy sour...ical study, Lauren Akers, D.O., postdoctoral fello...erson, found that combining a novel glycolysis inh...duced more than 90 percent cell death in human tis...
(Date:5/16/2008)...hs School of Nursing and Midwifery, has won the In...an Nursing Awards. , Professor Rickard won top ... during testing procedures, reducing the risk of a...lready ill patients. The award was announced last ...inment complex. , Nurses routinely take blood s...
Breaking Medicine News(10 mins):Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2Health News:Childhood Cancer Survivors Prone to Early Heart Trouble 2Health News:Childhood Cancer Survivors Prone to Early Heart Trouble 3Health News:New drug combination brings 1-2 punch against acute leukemia 2Health News:Research talent wins national Innovation in Nursing award 2
Other TagsDimensionDimensionDimensionOther Tagsmicrobe 2shortage 2lock 2pharmaceuticals 2spreading 2spreading 3spreading 4